Cognition and Immunity

  • Kowal C
  • DeGiorgio L
  • Nakaoka T
  • et al.
N/ACitations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Patients with lupus (SLE) experience progressive cog- nitive loss without evidence of CNS vascular disease or inflammation. SLE patients produce anti-DNA anti- bodies that crossreact with NMDA receptors and are capable of mediating excitotoxic death. We now show that mice induced by antigen to express these anti- bodies have no neuronal damage until breakdown of the blood-brain barrier occurs. Following administra- tion of lipopolysaccharide (LPS) to immunized mice, antibodies gain access to the brain. They bind pref- erentially to hippocampal neurons and cause neuronal death with resulting cognitive dysfunction and altered hippocampalmetabolismon magnetic resonance spec- troscopy. Memantine, an NMDA receptor antagonist, given prior to LPS administration, prevents neuronal damage.Thus, systemicimmuneresponses cancause cognitive impairment in the absence of an inflamma- tory cascade, implicating the immune system in yet another arena of human pathobiology. Furthermore, NMDA receptor antagonists prevent antibody-medi- ated damage and may constitute a new approach to therapy in SLE.

Cite

CITATION STYLE

APA

Kowal, C., DeGiorgio, L. A., Nakaoka, T., Hetherington, H., Huerta, P. T., Diamond, B., & Volpe, B. T. (2004). Cognition and Immunity. Immunity, 21(2), 179–188. https://doi.org/10.1016/j.immuni.2004.07.011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free